These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20733289)

  • 21. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shiga toxin-induced tubular injury in hemolytic uremic syndrome.
    Kaplan BS
    Kidney Int; 1998 Aug; 54(2):648-9. PubMed ID: 9690234
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemolytic uremic syndrome: long term renal injury].
    Lumbreras Fernández J; Cruz Rojo J; Iñigo Martín G; Muley Alonso R; Vara Martín J
    An Pediatr (Barc); 2010 May; 72(5):309-16. PubMed ID: 20347408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of interleukin-10 reduces progression of shiga toxin-induced hemolytic uremic syndrome.
    Pineda GE; Rearte B; Todero MF; Bruballa AC; Bernal AM; Fernandez-Brando RJ; Isturiz MA; Zotta E; Alba-Soto CD; Palermo MS; Ramos MV
    Clin Sci (Lond); 2021 Feb; 135(3):575-588. PubMed ID: 33496327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic uremic syndrome: pathogenesis and update of interventions.
    Palermo MS; Exeni RA; Fernández GC
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):697-707. PubMed ID: 19681698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal administration of shiga toxin type 2 in rats in the late stage of pregnancy produces premature delivery of dead fetuses.
    Burdet J; Zotta E; Franchi AM; Ibarra C
    Placenta; 2009 Jun; 30(6):491-6. PubMed ID: 19395083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome.
    Ohara S; Kawasaki Y; Abe Y; Watanabe M; Ono A; Suyama K; Hashimoto K; Honda T; Suzuki J; Hosoya M
    Am J Nephrol; 2012; 36(6):516-23. PubMed ID: 23171542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of silencing transforming growth factor-beta1 by RNAi upon transdifferentiation of renal allograft tubular epithelial cells in rats].
    Xia YG; Wu XH; Yin ZK; Luo CL; Zhang JM; Cheng HL
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3151-5. PubMed ID: 20193281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the endothelium in hemolytic uremic syndrome.
    Zoja C; Morigi M; Remuzzi G
    J Nephrol; 2001; 14 Suppl 4():S58-62. PubMed ID: 11798147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndrome.
    Bitzan M; Bickford BB; Foster GH
    J Am Soc Nephrol; 2004 Sep; 15(9):2334-43. PubMed ID: 15339982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease.
    Keepers TR; Psotka MA; Gross LK; Obrig TG
    J Am Soc Nephrol; 2006 Dec; 17(12):3404-14. PubMed ID: 17082244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
    Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
    Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat.
    Cattell V
    Am J Pathol; 1985 Oct; 121(1):88-95. PubMed ID: 3876775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.
    Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA
    Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome.
    Ray PE; Liu XH; Xu L; Rakusan T
    Pediatr Nephrol; 1999 Sep; 13(7):586-93. PubMed ID: 10460507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
    Orth D; Khan AB; Naim A; Grif K; Brockmeyer J; Karch H; Joannidis M; Clark SJ; Day AJ; Fidanzi S; Stoiber H; Dierich MP; Zimmerhackl LB; Würzner R
    J Immunol; 2009 May; 182(10):6394-400. PubMed ID: 19414792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolytic uremic syndrome: an emerging health risk.
    Razzaq S
    Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.